✦ LIBER ✦

P-23 The combination of gemcitabine (G) and cisplatin (P) in the general population of elderly patients with advanced NSCLC

✍ Scribed by Moscetti, Luca; Saltarelli, Rosa; Signorelli, Carlo; Padalino, Domenico; De Marco, Salvatore; Capomolla, Elisabetta; Francesco Pollera, Camillo

Book ID: 118571724
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 381 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)91992-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-202 Phase II trial of tirapazamine in

P-202 Phase II trial of tirapazamine in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer (NSCLC)

✍ Reck, Martin; von Pawel, Joachim; Nimmermann, Christa; Groth, Gesine; Gatzemeier 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Pharmacology of the paclitaxel–cisplatin

Pharmacology of the paclitaxel–cisplatin, gemcitabine–cisplatin, and paclitaxel–gemcitabine combinations in patients with advanced non-small cell lung cancer

✍ J. R. Kroep; E. F. Smit; G. Giaccone; K. Van der Born; J. H. Beijnen; C. J. Van 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 248 KB

P-38 Retrospective analysis of combined

P-38 Retrospective analysis of combined cisplatin (P) and etoposide (E) regimen tolerability in the elderly (≥65 years) and non-elderly (<65 years) patients (pts) with advanced non-small-cell lung cancer (NSCLC)

✍ Gorbounova, Vera; Besova, Natalia; Mindra, Natalia; Markovich, Alla 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 194 KB

PCN16 A COMPARISON OF THE COSTS OF GEMCI

PCN16 A COMPARISON OF THE COSTS OF GEMCITABINE/CISPLATIN AND GEMCITABINE/CARBOPLATIN COMBINATION REGIMENS IN THE TREATMENT OF ADVANCED NSCLC IN THE UK AND FRANCE

✍ DP Tilden; M Aristides; G Stynes; A Kielhorn; S Bhalla 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

P-548 Prolonged infusion (PI) of gemcita

P-548 Prolonged infusion (PI) of gemcitabine (G) in combination with cisplatin (C) in patients with advanced non-small cell lung cancer (NSCLC): preliminary results of a dose-finding and pharmacokinetic (PK) study

✍ Caffo, Orazio; Binato, Samuela; Santo, Antonio; Giovannini, Monica; Lucenti, Ant 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 171 KB

1087 Study of the combination MIC (mitom

1087 Study of the combination MIC (mitomycin, ifosfamide and cisplatin) in advanced NSCLC

✍ Teixeira, E.; Sotto-Mayor, R.; Azevedo, P.; Preto, P.; Maçanita, J.; Freitas e C 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 155 KB